• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emergent Biosolutions Inc

+ Add to Watchlist

EBS:US

24.9350 USD 0.0650 0.26%

As of 15:21:47 ET on 08/29/2014.

Snapshot for Emergent Biosolutions Inc (EBS)

Open: 25.0000 Day's Range: 24.6325 - 25.4100 Volume: 102,126
Previous Close: 24.8700 52wk Range: 17.1400 - 28.4800 1-Yr Rtn: +41.84%

Stock Chart for EBS

No chart data available.
  • EBS:US 24.9000
  • 1D
  • 1M
  • 1Y
24.8700
Interactive EBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EBS

Current P/E Ratio (ttm) 44.4592
Estimated P/E(12/2014) 27.5634
Relative P/E vs. SPX 2.4744
Earnings Per Share (USD) (ttm) 0.5623
Est. EPS (USD) (12/2014) 0.9070
Est. PEG Ratio -
Market Cap (M USD) 936.93
Shares Outstanding (M) 37.48
30 Day Average Volume 203,134
Price/Book (mrq) 1.9367
Price/Sale (ttm) 2.6079
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EBS

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences Div
More Company Profile & Key Executives for EBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil